Quarterly Results

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : MiscellaneousHouse : Sun Pharma
BSE171.203.15 (+1.87 %)
PREV CLOSE ( ) 168.05
OPEN PRICE ( ) 169.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 26830
TODAY'S LOW / HIGH ( )169.30 174.95
52 WK LOW / HIGH ( )81 210.7
NSE171.253.05 (+1.81 %)
PREV CLOSE( ) 168.20
OPEN PRICE ( ) 169.30
BID PRICE (QTY) 171.25 (1468)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 684384
TODAY'S LOW / HIGH( ) 168.70 175.00
52 WK LOW / HIGH ( )81 210.9
Quarters
Select year  
( in Million)
Particulars
Jun 2020
Mar 2020
Dec 2019
Sep 2019
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
1854.5
227.1
196
171.9
Total Expenditure
1246.7
1210.7
733.1
801.1
PBIDT (Excl OI)
607.8
-983.6
-537.1
-629.2
Other Income
6.6
31.2
7.1
22.6
Operating Profit
614.4
-952.4
-530
-606.6
Interest
19.7
15.7
2.6
2.5
Exceptional Items
NA
NA
NA
NA
PBDT
594.7
-968.1
-532.6
-609.1
Depreciation
27.8
27.3
22.5
22.5
Profit Before Tax
566.9
-995.4
-555.1
-631.6
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
566.9
-995.4
-555.1
-631.6
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
NA
NA
Net Profit
566.9
-995.4
-555.1
-631.6
Equity Capital
262.1
262.1
262.1
262.1
Face Value (IN RS)
1
1
1
1
Reserves
Calculated EPS
2.16
-3.79
-2.11
-2.40
Calculated EPS (Annualised)
8.65
-15.19
-8.47
-9.63
No of Public Share Holdings
82640276
82640276
82640276
82640276
% of Public Share Holdings
31.54
31.54
31.54
31.54
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
32.77
-433.11
-274.03
-366.02
PBIDTM%
33.13
-419.37
-270.40
-352.87
PBDTM%
32.06
-426.28
-271.73
-354.33
PBTM%
30.56
-438.30
-283.21
-367.42
PATM%
30.56
-438.30
-283.21
-367.42
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)